Back to top

crispr: Archive

Zacks Equity Research

CRISPR Therapeutics' (CRSP) Pipeline Development Fuels Growth

While CRISPR Therapeutics' (CRSP) lead candidate is still a couple of years away from commercialization, it is highly dependent on collaboration revenues to fund its ongoing pipeline.

VRTXPositive Net Change CRSPPositive Net Change SESNPositive Net Change